KUALA LUMPUR (Aug 7): Trading in LYC Healthcare Bhd (KL:LYC) shares will be suspended from Monday (Aug 10), after the healthcare group failed to submit its overdue annual report.
The operator of confinement centres and aesthetic clinics said it is still unable to release its annual report for the financial year ended in March 31, 2026 (FY2026), as its audited financial statements are pending finalisation by external auditor SBY partners PLT. It was due on Friday, Aug 7, 2026.
The group now expects to issue and submit the annual report within two weeks from Friday, LYC Healthcare said in a bourse filing.
LYC Healthcare previously expected to submit the report by Aug 7 after missing the original July 31 deadline. Bursa Malaysia had warned that trading in the group’s securities would be suspended from 9am on Aug 10 if the report was not submitted by Friday.
LYC Healthcare said its management has been working closely with SBY Partners to expedite the completion of the audit.
The delay came after LYC Healthcare appointed SBY Partners as its new external auditor on March 6, following the resignation of Crowe Malaysia PLT on Feb 26 over a disagreement on audit fees.
LYC Healthcare has been loss-making since FY2012. For FY2026, its net loss widened to RM23.27 million from RM17.07 million a year earlier, while revenue fell 13.7% to RM134.19 million from RM155.52 million.
As at end-March, the group had accumulated losses of RM112.9 million, cash and bank balances of RM17.47 million and total borrowings of RM73.3 million, the bulk of which comprised redeemable preference shares.
Shares of LYC Healthcare were unchanged at half a sen on Friday, giving it a market capitalisation of RM3.7 million.